Histogen Update - Spencer Kobren Speaks With Dr. Craig L. Ziering

[Pate]

Latanoprost is an older drug than bimatoprost, in fact the patent has already expired so it's available generic.

Latanoprost is also, I believe, the drug that was tested on macaque monkeys with MPB, some years ago now.

It's one of those drugs that's been around for years and but never made it on to the market for MPB, presumably because of the belief its effectiveness is limited and it would cost too much to get it through trials.

One of the depressing, constant themes of hair loss drug development. So many drugs offer more potential than minox or fin but are never developed for commercial reasons, so we're stuck with those two dinosaurs.

Hopefully the bimatoprost results are positive and Allergan rush to Phase III, knowing they will have Histogen breathing down their necks. I personally believe bimatoprost is the only new treatment we've got a chance of seeing this side of 2015.